Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.25 is 38% above its 3-year average of 0.91, around the middle of its 3-year range (0.00–2.74).
As of the fiscal period ended Tuesday, June 30, 2026. 29.96% below its 12-month average of 1.78.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.25.
QUICK RATIO (ACID-TEST)
1.25
QUICK RATIO (ACID-TEST) AVG TTM
1.78
QUICK RATIO (ACID-TEST) AVG 3Y
0.98
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-29.96%
CURRENT VS 3Y AVG
+27.68%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 503 covered companies
CURRENT VS SECTOR MEDIAN
-58.27%
vs the sector median at left
Actuate Therapeutics Inc
Market Cap
$20.93M
Quick Ratio (Acid-Test)
1.25
TTM Avg
1.78
3Y Avg
0.98
5Y Avg
N/A
Market Cap
$21.90M
Quick Ratio (Acid-Test)
1.00
TTM Avg
1.04
3Y Avg
0.94
5Y Avg
0.89
Market Cap
$18.82M
Quick Ratio (Acid-Test)
0.92
TTM Avg
0.83
3Y Avg
1.35
5Y Avg
1.29
Market Cap
$18.77M
Quick Ratio (Acid-Test)
0.20
TTM Avg
0.34
3Y Avg
6.34
5Y Avg
6.11
Market Cap
$24.44M
Quick Ratio (Acid-Test)
5.69
TTM Avg
10.26
3Y Avg
14.54
5Y Avg
17.67
Market Cap
$24.65M
Quick Ratio (Acid-Test)
2.59
TTM Avg
2.35
3Y Avg
1.92
5Y Avg
2.36
Market Cap
$16.58M
Quick Ratio (Acid-Test)
1.96
TTM Avg
1.25
3Y Avg
1.80
5Y Avg
4.00
Market Cap
$16.54M
Quick Ratio (Acid-Test)
1.65
TTM Avg
3.34
3Y Avg
3.94
5Y Avg
7.05
Market Cap
$25.48M
Quick Ratio (Acid-Test)
0.07
TTM Avg
0.37
3Y Avg
0.39
5Y Avg
0.82
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Actuate Therapeutics Inc (ACTU) | $20.93M | 1.25 | 1.78 | 0.98 | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | 1.00 | 1.04 | 0.94 | 0.89 |
| Cosmos Health Inc. (COSM)vs › | $18.82M | 0.92 | 0.83 | 1.35 | 1.29 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | 0.20 | 0.34 | 6.34 | 6.11 |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | 5.69 | 10.26 | 14.54 | 17.67 |
| Kyntra Bio, Inc. (KYNB)vs › | $24.65M | 2.59 | 2.35 | 1.92 | 2.36 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | 1.96 | 1.25 | 1.80 | 4.00 |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | 1.65 | 3.34 | 3.94 | 7.05 |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | 0.07 | 0.37 | 0.39 | 0.82 |
| BioCardia, Inc. (BCDA)vs › | $16.22M | 2.09 | 1.13 | 1.21 | 2.30 |
Quick Ratio
1.25
Excludes inventory
Current Ratio
1.25
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.25 |
| 2026-03-31 | 1.80 |
| 2025-12-31 | 2.39 |
| 2025-09-30 | 2.74 |
| 2025-06-30 | 0.73 |
| 2025-03-31 | 0.46 |
| 2024-12-31 | 1.05 |
| 2024-09-30 | 1.68 |
| 2024-06-30 | 0.03 |
| 2024-03-31 | 0.15 |
| 2023-12-31 | 0.43 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
